Iron Overload and Chelation in Thalassaemia |
Contents
Preface | 9 |
Toxicity of desferrioxamine treatment | 26 |
Use of computed tomography in the management of iron overload | 34 |
Copyright | |
1 other sections not shown
Common terms and phrases
59Fe-labelled alloimmunisation amount of iron ascorbate auditory B-thal B++/B++ or B++/B+ bile blood consumption blood transfusion Bth/8B high Bth/8th silent Callender Chelation in Thalassaemia chelation therapy CHRISTOS KATTAMIS clinical compliance computed tomography correlation deferoxamine Desferal dose of desferrioxamine effects Erythropoiesis faecal iron excretion ferrioxamine ferritin levels follow-up GABUTTI Genotypes growth failure Growth rate Haematol haemochromatosis haemoglobin haemosiderosis Hb-H hearing loss Hemoglobinopathies hepatic hepatocytes HERSHKO high F homozygous homozygous sickle cell hypersplenism IL2 receptor increased infusion of desferrioxamine intravenous infusion iron input iron load iron-chelating agents LAC rose Lancet Lepore LETSKY liver biopsy management of iron metabolism mg/kg bodyweight negative iron balance Northwick Park Hospital OLIVIERI patients receiving patients with thalassaemia PIPPARD prevent iron overload PROPPER reduced regularly transfused Serum ferritin ng/ml sickle cell anaemia splenectomy subcutaneous infusion Table thalassaemia intermedia thalassaemic patients threshold total iron stores transferrin urinary iron excretion urine variation in LAC WEATHERALL